Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Mr. Jeffrey A. Meckler$21.5M
Market Cap • 18/04/20242021
(há 3 anos)
2021
(3 years ago)
NASDAQ
Listagem
New York
Sede • New York6
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
INDPSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.